No regulatory approvals required for cell therapy use. Absolute nonsense. PMA would be required in the US unless they can find a predicate device to file a 510(k). Different path in Europe but likely same issue.
PNV Price at posting:
$1.49 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)